Elena Luison

654 total citations
22 papers, 532 citations indexed

About

Elena Luison is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Elena Luison has authored 22 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Elena Luison's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Elena Luison is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Elena Luison collaborates with scholars based in Italy, Germany and Switzerland. Elena Luison's co-authors include Silvana Canevari, Mariangela Figini, Delia Mezzanzanica, Marina Bagnoli, Ettore Seregni, Emilio Bombardieri, Angela Coliva, Renata Ferri, Mario P. Colombo and Giovanni Paganelli and has published in prestigious journals such as Clinical Cancer Research, Nanoscale and Biochemical Pharmacology.

In The Last Decade

Elena Luison

21 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Luison Italy 15 246 224 166 107 73 22 532
Le-Cun Xu United States 8 226 0.9× 172 0.8× 246 1.5× 42 0.4× 63 0.9× 12 608
Desirée L. Bos Netherlands 15 159 0.6× 216 1.0× 149 0.9× 90 0.8× 93 1.3× 33 573
Sébastien Gouard France 18 159 0.6× 450 2.0× 259 1.6× 87 0.8× 178 2.4× 37 758
Iwao Ohizumi Japan 13 392 1.6× 136 0.6× 154 0.9× 126 1.2× 30 0.4× 23 729
Amelia M. Huehls United States 10 395 1.6× 144 0.6× 488 2.9× 166 1.6× 35 0.5× 15 704
Leslie Wetzel United States 7 188 0.8× 297 1.3× 459 2.8× 166 1.6× 83 1.1× 11 661
Heather Kostner United States 7 263 1.1× 208 0.9× 413 2.5× 102 1.0× 38 0.5× 12 624
Beate Müller‐Tiemann Germany 9 305 1.2× 213 1.0× 224 1.3× 60 0.6× 84 1.2× 12 548
Michael A. Dengler Germany 14 455 1.8× 51 0.2× 109 0.7× 66 0.6× 118 1.6× 24 706
Lynsey A. Huxham Canada 13 276 1.1× 100 0.4× 300 1.8× 195 1.8× 85 1.2× 15 806

Countries citing papers authored by Elena Luison

Since Specialization
Citations

This map shows the geographic impact of Elena Luison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Luison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Luison more than expected).

Fields of papers citing papers by Elena Luison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Luison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Luison. The network helps show where Elena Luison may publish in the future.

Co-authorship network of co-authors of Elena Luison

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Luison. A scholar is included among the top collaborators of Elena Luison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Luison. Elena Luison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luison, Elena, Alessandro Desideri, Federico Iacovelli, et al.. (2021). Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review. Biomedicines. 9(12). 1870–1870. 4 indexed citations
2.
Ciniselli, Chiara Maura, Loris De Cecco, Elena Luison, et al.. (2021). SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region. Cancers. 13(5). 1035–1035.
3.
Luison, Elena, Ettore Seregni, Alice Lorenzoni, et al.. (2019). Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle. Journal of Experimental & Clinical Cancer Research. 38(1). 326–326. 15 indexed citations
4.
Franssen, Gerben M., Elena Luison, Ettore Seregni, et al.. (2016). Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging. Oncotarget. 8(7). 10919–10930. 17 indexed citations
5.
Benigni, Fabio, Elena Luison, Ettore Seregni, et al.. (2015). Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen. Immunology Letters. 168(1). 105–110. 10 indexed citations
6.
Doro, Fábio Gorzoni, Cinzia Colombo, Chiara Alberti, et al.. (2015). Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions. Organic & Biomolecular Chemistry. 13(9). 2570–2573. 15 indexed citations
7.
Quarta, Alessandra, Davide Bernareggi, Fabio Benigni, et al.. (2014). Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo. Nanoscale. 7(6). 2336–2351. 27 indexed citations
8.
Fracasso, Giulio, Elena Luison, Sara Cingarlini, et al.. (2013). A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer. European Journal of Cancer. 49(9). 2223–2232. 46 indexed citations
9.
Perego, Paola, Giacomo Cossa, Stella Tinelli, et al.. (2011). Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition. Biochemical Pharmacology. 83(1). 27–36. 35 indexed citations
10.
Martin, Franck, Elena Luison, Angela Coliva, et al.. (2011). Antitumor Effects of a Human Dimeric Antibody Fragment 131I-AFRA-DFM5.3 in a Mouse Model for Ovarian Cancer. Journal of Nuclear Medicine. 52(12). 1938–1946. 14 indexed citations
11.
Coliva, Angela, Elena Luison, Ettore Seregni, et al.. (2009). 177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts. Nuclear Medicine and Biology. 36(7). 759–770. 23 indexed citations
12.
Figini, Mariangela, Franck Martin, Renata Ferri, et al.. (2008). Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor. Cancer Immunology Immunotherapy. 58(4). 531–546. 19 indexed citations
13.
Bagnoli, Marina, Emanuela Balladore, Elena Luison, et al.. (2007). Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment. Molecular Cancer Therapeutics. 6(2). 762–772. 20 indexed citations
14.
Coliva, Angela, Elena Luison, Antonella Tomassetti, et al.. (2005). 90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas. Cancer Immunology Immunotherapy. 54(12). 1200–1213. 29 indexed citations
15.
Figini, Mariangela, Renata Ferri, Delia Mezzanzanica, et al.. (2003). Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies. Gene Therapy. 10(12). 1018–1025. 55 indexed citations
16.
Turatti, Fabio, Delia Mezzanzanica, Elena Nardini, et al.. (2001). Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2. Cancer Immunology Immunotherapy. 49(12). 679–686. 8 indexed citations
17.
Chinol, Marco, et al.. (2001). The humoral immune response to macrocyclic chelating agent DOTA depends on the carrier molecule.. PubMed. 42(11). 1697–703. 12 indexed citations
18.
Mezzanzanica, Delia, Elena Luison, Paola Alberti, et al.. (2000). Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1. Cancer Immunology Immunotherapy. 49(6). 296–304. 6 indexed citations
19.
Melani, Cecilia, Mariangela Figini, Elena Luison, et al.. (1998). Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.. PubMed. 58(18). 4146–54. 53 indexed citations
20.
Casalini, Patrizia, Elena Luison, Sylvie Ménard, et al.. (1997). Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.. PubMed. 38(9). 1378–81. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026